Literature DB >> 2036500

Phobias and related anxiety disorder.

I Marks.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2036500      PMCID： PMC1669645          DOI： 10.1136/bmj.302.6784.1037

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

1.  Home-based treatment of obsessive-compulsive patients: intersession interval and therapist involvement.

Authors:  P M Emmelkamp; C van Linden van den Heuvell; M Rüphan; R Sanderman
Journal:  Behav Res Ther       Date:  1989

Review 2.  Drugs and psychological treatments for agoraphobia/panic and obsessive-compulsive disorders: a review.

Authors:  I Marks; G O'Sullivan
Journal:  Br J Psychiatry       Date:  1988-11       Impact factor: 9.319

3.  Use of a portable-computer program in behavioral treatment of obsessive-compulsive disorder.

Authors:  L Baer; W E Minichiello; M A Jenike
Journal:  Am J Psychiatry       Date:  1987-08       Impact factor: 18.112

4.  Ambulatory computer-assisted therapy for obesity: a new frontier for behavior therapy.

Authors:  K F Burnett; C B Taylor; W S Agras
Journal:  J Consult Clin Psychol       Date:  1985-10

5.  Therapist contact and outcome of self-exposure treatment for phobias. A controlled study.

Authors:  A Ghosh; I M Marks; A C Carr
Journal:  Br J Psychiatry       Date:  1988-02       Impact factor: 9.319

6.  Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals.

Authors:  I M Marks; P Lelliott; M Basoglu; H Noshirvani; W Monteiro; D Cohen; Y Kasvikis
Journal:  Br J Psychiatry       Date:  1988-04       Impact factor: 9.319
  6 in total
  1 in total

1.  Reduction of claustrophobia with short-bore versus open magnetic resonance imaging: a randomized controlled trial.

Authors:  Judith Enders; Elke Zimmermann; Matthias Rief; Peter Martus; Randolf Klingebiel; Patrick Asbach; Christian Klessen; Gerd Diederichs; Moritz Wagner; Ulf Teichgräber; Thomas Bengner; Bernd Hamm; Marc Dewey
Journal:  PLoS One       Date:  2011-08-22       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.